An IQVIA Virtual Conference

Real world evidence (RWE) is creating a new world of possibilities across all therapeutic areas, helping demonstrate treatment value and commercial differentiation, spanning stakeholders throughout the life cycle.

The growing acceptance of RWE by regulators and payers means growing utility of RWE -- to enhance clinical development, to innovate reimbursement models, to help drive research forward, and to accelerate patient access to new treatments.

With technology-enabled real world data and evidence, you can efficiently demonstrate the impact RWE brings to your portfolio:

• Gain insights that support new or improved treatment pathways
• Discover and leverage increasingly available data sources and collection methods
• Leverage advanced analytics to help identify undiagnosed patients and drive earlier prediction of disease progression.

Join this upcoming virtual conference to learn how you can efficiently demonstrate the impact RWE brings to your portfolio.

Speakers

	Julie van Bavel Executive Director CORE Regional, Asia Pacific MSD		Taara Madhavan Regional Evidence Generation Lead Asia Pacific Medical Affairs Janssen
	Paul Petraro, ScD., MPH Global Head RWE Analytics Center of Excellence, Real World Solutions Boehringer Ingelheim		Sulabha Ramachandran Vice President US and Regions, Value Evidence and Outcomes GSK
	Gorana Capkun Global Head RWE Enablement Novartis Oncology		Enkeleida Nikai Head of Real World Evidence Senior Director Janssen Europe